Hummingbird Bioscience
PrivateLast Round
Series C
May 18, 2021
Total Funding Raised
$163.1M
Momentum Score
25 /100
Company Overview
Hummingbird Bioscience is a biotechnology company that develops innovative therapeutic antibody-based drugs aimed at addressing the significant unmet needs of oncology and immuno-oncology patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hummingbird Bioscience Comps
Public and private peers based on sector, stage, and business model.
Hummingbird Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2021 | ||||
| Series B Extension | May 11, 2020 | ||||
| Series B | Dec 4, 2019 | ||||
| Series A Extension | Jul 15, 2019 | ||||
| Grant | Feb 25, 2019 | ||||
Series A | May 3, 2017 |
Key People
Founding team and executive leadership
Hummingbird Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heritas Capital Management | Series B, Series C, Series B Extension, Series A Extension |
| Frazier Healthcare Partners | Series C |
| SEEDS Capital | Series B, Series C, Series B Extension, Series A Extension |
| Mirae Asset | Series B, Series C |
| Octagon Capital Advisors | Series C |
| Ally Bridge Group | Series C |
| Morningside Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2025
Clinical-stage monoclonal antibodies and antibody-drug conjugates in oncology and autoimmunity.
Hummingbird Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hummingbird Bioscience's valuation, stock price, and market status.
